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  It has been reported that activation of metabotropic glutamate receptor 1 (mGluR1) can mediate 
endocannabinoid-induced short-term depression of synaptic transmission in cerebellar parallel fiber 
(PF)-Purkinje cell (PC) synapse. mGluR1 has signaling pathways involved in intracellular calcium 
increase which may contribute to endocannabinoid release. Two major mGluR1-evoked calcium 
signaling pathways are known: (1) slow-kinetic inward current carried by transient receptor potential 
canonical (TRPC) channel which is permeable to Ca
2＋; (2) IP3-induced calcium release from intra-
cellular calcium store. However, it is unclear how much each calcium source contributes to 
endocannabinoid signaling. Here, we investigated whether calcium influx through mGluR1-evoked 
TRPC channel contributes to endocannabinoid signaling in cerebellar Purkinje cells. At first, we applied 
SKF96365 to inhibit TRPC, which blocked endocannabinoid-induced short-term depression completely. 
However, an alternative TRP channel inhibitor, BTP2 did not affect endocannabinoid-induced 
short-term depression although it blocked mGluR1-evoked TRPC currents. Endocannabinoid signaling 
occurred normally even though the TRPC current was mostly blocked by BTP2. Our data imply that 
TRPC current does not play an important role in endocannabinoid signaling. We also suggest 
precaution in applying SKF96365 to inhibit TRP channels and propose BTP2 as an alternative TRPC 
inhibitor.
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INTRODUCTION
  Metabotropic glutamate receptors (mGluRs) are a type 
of G-protein coupled receptor that modulate protein ex-
pression, neurotransmission and neuronal excitability 
throughout the CNS [1-4]. mGluR1 is a member of a Group 
I mGluR that is expressed in cerebellar Purkinje cells and 
in many other postsynaptic neurons. Activation of mGluR1 
induces several cellular events in cerebellar Purkinje cells 
like the activation of PLC-β-IP3 signal cascade [5,6] or slow 
excitatory postsynaptic currents (EPSCs) [7,8]. Slow cur-
rents are known to be mediated by transient receptor po-
tential canonical (TRPC) channels [8]. Slow currents are 
non-selective cation currents which include Na
＋ and Ca
2＋ 
influxes [9] so it may elevate intracellular Ca
2＋ concen-
tration in cerebellar Purkinje cells. The function of such 
slow currents is still unknown, however.
  Delta-9-tetrahydrocannabinol (Δ9-THC), the principal 
psychoactive constituent of marijuana affects brain func-
tion by activating the G-protein coupled receptor, cannabi-
noid receptor-1 (CB1R) [10,11], which is expressed through-
out the brain [12]. Two major endogenous ligands of the 
receptor, 2-arachidonylglycereol (2-AG) and anandamide 
are known so far [13,14]. Endocannabinoids function as a 
retrograde messenger that contributes to long-term and 
short-term plasticity in the CNS [15-17]. It is reported that 
strong depolarization of postsynaptic neurons [18,19] or ad-
ministration of mGluR agonists [20,21] can suppress pre-
synaptic transmitter release and diminish EPSCs. It is 
found that the depression of EPSCs has an endocannabi-
noid-dependent mechanism and three different models for 
the mechanism of endocannabinoid release have been 
suggested. Endocannabinoids are released by large ele-
vation of calcium concentration in the postsynaptic neuron 
that is usually induced by strong depolarization (depolari-
zation-induced suppression of inhibition/excitation, DSI/ 
DSE), strong activation of G protein-coupled receptors 
(receptor-driven endocannabinoid release, RER), or simul-
taneous small elevations of calcium concentration and weak 140 W Chang, et al
Fig. 1. PF burst induced Endocannabinoid-mediated short-term 
depression in cerebellar Purkinje cell. (A) The induction protocol 
for transient depression and trace in induction. 10 parallel fiber 
stimuli were applied at 100 Hz in current clamp mode. (B) EPSPs 
before induction and 5 s after induction. (Top: control, bottom: 3 
μM of AM251 applied, Black: before induction, Grey: 5 s after 
induction) (C) EPSPs were evoked by a single pulse of PF stimulus 
during an 80 seconds baseline and for 60 seconds after induction 
of transient depression. After that, 3 μM of AM251 was applied 
for 10 minutes, and then recording of baseline and induction of 
transient depression were established in the same cell. Amplitudes 
of EPSPs were normalized to baseline before and after application 
of AM251. (D) Summary bar graphs showing change of depression 
of EPSPs after application of AM251.
receptor activation (Ca
2＋-assisted RER, Ca-RER) and acts 
presynaptically to suppress neurotransmitter release. 
Unlike DSE/DSI, Ca-RER can be induced by weak elevation 
of calcium, which can be mediated by calcium sources other 
than the voltage-operated calcium channel (VOCC) like the 
Endoplasmic reticulum (ER) calcium store or TRPC. It was 
reported that ER calcium release do not have a role in the 
induction of Ca-RER [22], indicating it is more worthwhile 
to investigate the role of TRPC in endocannabinoid release. 
Here, we investigated whether endocannabinoid-induced 
retrograde signaling is regulated by the TRPC-induced slow 
current. We induced transient depression of synaptic trans-
mission by PF burst stimulation in current clamp mode and 
associative stimulation of parallel fiber (PF) burst and 
Purkinje cell (PC) depolarization in voltage clamp mode; 
however, neither was affected by TRPC blockers. This sug-
gests TRPC mediated slow currents and calcium transients 
do not play an important role in the endocannabinoid sig-
naling and that calcium sources other than TRPC is needed 
for Ca-RER.
METHODS
  Parasagittal brain slices of the cerebellar vermis (250 μm 
thick) were prepared from P15-P20 Sprague-Dawley rats 
using a vibrating tissue slicer and ice-cold standard artifi-
cial cerebrospinal fluid (ACSF) containing 124 mM NaCl, 
2.5 mM KCl, 1 mM Na2HPO4, 1.3 mM MgCl2, 2.5 mM 
CaCl2, 26.2 mM NaHCO3, and 20 mM D-glucose, bubbled 
with 95% O2 and 5% CO2. After cutting, slices were kept 
for 30 min at 35
oC and then for up to 8 hrs. at 25
oC in 
ACSF.
  After a recovery period, the slices were placed in a sub-
merged chamber that was perfused at a rate of 2 ml/min 
with ACSF supplemented with either 100 μM picrotoxin 
to block GABAA receptors. Somatic whole-cell recording 
were obtained by using an EPC8 amplifier (HEKA 
Instruments Inc., Bellmore, NY). The recording electrodes 
(resistance 2∼4 MΩ) were filled with a solution containing 
130 mM K-gluconate, 10 mM KCl, 10 mM HEPES, 0.2 
EGTA, 10 mM Na2-phosphocreatine, 3 mM Mg2ATP, 0.3 
mM Na3GTP (pH 7.25) for current-clamp recording and 135 
mM Cs-methanesulfonate, 10 mM CsCl, 10 mM HEPES, 
4 mM Mg2ATP, 0.4 mM Na3GTP, and 0.2 mM EGTA (pH 
7.25) for voltage-clamp recordings. Currents were filtered 
at 1 kHz, digitized at 5 kHz, and acquired using Pulse 
(HEKA Instruments). For parallel fiber stimulation, stand-
ard patch pipettes were used that were filled with external 
saline and placed in the middle third of the molecular layer. 
Synaptic responses were evoked every 30 s using 20∼40 
μA pulses (100 μs duration). When burst stimulation was 
employed, the interpulse interval was 10 ms. Recordings 
were performed at RT in ACSF.
  All group data are shown as mean±SEM. Comparisons 
were made using Student's t tests. All drugs were pur-
chased from Sigma (St. Louis, MO) except for CPCCOEt, 
NBQX, AM251, SKF96365 (Tocris Cookson, Ballwin, MO).
RESULTS
  Several studies demonstrated that brief burst of parallel 
fiber can trigger retrograde inhibition of the PF-PC synapse 
[16,22]. This phenomenon is termed as Ca-RER and is 
mGluR-PLCβ4 dependent. To mimic this Ca-RER, we 
made whole-cell patch clamp recordings from cerebellar 
Purkinje cells in cerebellar slices and recorded parallel fi-
ber-Purkinje cell (PF-PC) excitatory postsynaptic potentials 
(EPSPs) every 2 s, then applied short burst PF stimulation 
(100 Hz×10) (Fig. 1A). Subsequent EPSCs were depressed 
transiently (Fig. 1B, C, D; 52.05±10.57%, n=5), and this 
short-term depression was inhibited by 3 μM of cannabi-
noid receptor 1 blocker AM251 (Fig. 1B, C, D; −23.69± 
15.20%, n=5). Furthermore, in another set of experiments, 
short- term depression (Fig. 2; 49.73±25.25%, n=5) was also 
inhibited by 100 μM of CPCCOEt, an mGluR inhibitor 
(Fig. 2; −12.37±17.65%, n=5). This data shows that the de-
pression induced by burst stimulation of PF is CB1R and 
mGluR1-dependent RER.
  T R P C  i s  k n o w n  t o  m e d i a t e  s l o w  i n w a r d  c u r r e n t s  a c t i -
vated by mGluR1 in cerebellar Purkinje cells [8,23]. TRPC 
is a calcium-permeable non-selective cation channel, thus 
it is possible that TRPC functions as a calcium source in 
calcium-dependent cellular events. To investigate whether 
TRPC-mediated calcium influx contributes to Ca-RER, we 
applied SKF96365, a TRP channel inhibitor. The short- 
term depression (Fig. 3; 38.42±11.10%, n=5) was inhibited 
by 30 μM of SKF96365 (Fig. 3; −13.62±4.99%) signifi-
cantly. Regehr and his coworkers reported that associative 
stimulation can induce endocannabinoid signaling more ef-
fectively [22]. It is suggested that PF burst can cause a mas-
sive release of glutamate which can activate mGluR1 on 
the perisynaptic site of Purkinje cell dendritic spines, and 
climbing fiber (CF) can make global depolarization of 
Purkinje cell that may open VOCC, increasing the intra-Effects of TRPC Blockers on eCB Signaling 141
Fig. 2. PF burst-induced Endocannabinoid-mediated short-term 
depression is mGluR-dependent. (A) EPSPs before induction and 
5s after induction (Top: control, bottom: 100 μM of CPCCOEt 
applied, Black: before induction, Grey: 5 s after induction). (B) 
EPSPs were evoked by a single pulse of PF stimulus during an 
80 seconds baseline and for 60 seconds after induction of transient 
depression. After that, 100 μM of CPCCOEt was applied for 10 
minutes, and then recording of baseline and induction of transient 
depression were established in the same cell. Amplitudes of EPSPs 
were normalized to baseline before and after application of 
CPCCOEt. (C) Summary bar graphs showing change of depression 
of EPSPs after application of CPCCOEt.
Fig. 3. TRP blocker SKF96365 inhibited PF burst-induced 
Endocannabinoid-mediated short-term depression. (A) EPSPs 
before induction and 5 s after induction (Top: control, bottom: 30 
μM of SKF96365 applied, Black: before induction, Grey: 5 s after 
induction). (B) EPSPs were evoked by a single pulse of PF stimulus 
during an 80 seconds baseline and for 60 seconds after induction 
of transient depression. After that, 30 μM of SKF96365 was 
applied for 10 minutes, then recording of baseline and induction 
of transient depression were established in the same cell. 
Amplitudes of EPSPs were normalized to baseline before and after 
application of SKF96365. (C) Summary bar graphs showing change 
of depression of EPSPs after application of SKF96365.
cellular calcium concentration of the Purkinje cell. To mim-
ic this associative short-term depression and investigate 
the role of TRPC in the depression, we made whole-cell 
patch clamp recordings from cerebellar Purkinje cells in 
cerebellar slices and recorded PF-PC EPSCs, then applied 
associative stimulation consisting of short burst PF stim-
ulation (100 Hz×10) followed by 50 ms of depolarization of 
PC after 50 ms (Fig. 4A). The associative protocol induced 
short-term depression effectively (Fig. 4B, C, D; 50.03± 
14.84%, n=7), and SKF96365 decreased this depression par-
tially (Fig. 4B, C, D; 14.69±11.72%, n=7).
  Although we observed the effect of a TRP channel blocker, 
we had to confirm that TRPC specifically contributed to 
short-term plasticity since SKF96365 is known for its 
non-specificity [24,25], especially to VOCCs. To investigate 
whether TRPC-mediated calcium influx contribute to RER, 
we applied BTP2, another TRPC inhibitor. 1 μM of BTP2 
blocked most TRPC-induced currents in cultured cells in 
previous studies [26], however, the concentration of BTP2 
to block TRPC effectively in slices has not been reported. 
To find out the optimum concentration of BTP2 to block 
slow currents in brain slices, we induced TRPC-mediated 
slow current with parallel fiber burst (100 Hz×10 times) 
while applying NBQX (2.5 μM) to block the overlaying 
AMPAR current (Fig. 5A), and examined the concen-
tration-dependent effect of BTP2 on the amplitude of the 
slow current. 50 μM of BTP2 blocked the slow current in 
slice, while 25 μM or lower concentrations of BTP2 could 
not (Fig. 5B). Thus, we investigated whether 50 μM of 
BTP2 changed the amplitude of transient depression of 
EPSC in cerebellar slices. In cells which showed the depres-
sion by 10 times of parallel fiber burst on current clamp 
mode, 50 μM of BTP2 did not affect the amplitude of tran-
sient depression (Fig. 5C, D), although it was enough to 
block TRPC-mediated slow current almost completely. 
Furthermore, BTP2 did not affect short-term depression in-
duced by the associative protocol in the voltage clamp mode 
(Fig. 5E, F). This data indicates that TRPC-mediated slow 
current does not contribute to RER by the associative proto-
col we used and that the calcium influx through TRPC is 
overwhelmed by the calcium influx through VOCC or cal-
cium release from intracellular calcium stores.
DISCUSSION
  SKF96365 has been reported to elevate intracellular cal-
cium ion levels [27] and inhibit VOCCs [24,28] 򰠏 especially 
T-type calcium channels in cerebellar Purkinje cells [25], 
potassium channels [29,30], cytochrome P450 [31,32], and 
calcium ATPase [28,33]. SKF96365 blocked the endocanna-
binoid-induced depression effectively; we assumed the 
SKF96365 inhibited endocannabinoid release by reducing 
postsynaptic calcium increase through TRPC. However, 
BTP2, another blocker of TRP channel did not block RER, 
even though same concentration of BTP2 could block the 142 W Chang, et al
Fig. 4. TRP blocker SKF96365 inhibited endocannabinoid-mediated
short-term depression induced by association of PF burst and PC 
depolarization. (A) The induction protocol for transient depression 
and current trace in induction. 10 parallel fiber stimuli at 100 Hz 
and 50 ms of PC depolarization 50 ms after PF burst were applied 
in voltage clamp mode. (B) EPSCs before induction and 5 s after 
induction (Left: control, right: 30 μM of SKF96365 applied, Black: 
before induction, Grey: 5 s after induction). (C) EPSCs were evoked 
by a paired pulse of PF stimulus during a 40 seconds baseline and 
for 60 seconds after induction of transient depression. After that, 
30 μM of SKF96365 was applied for 10 minutes, and then record-
ing of baseline and induction of transient depression were 
established in the same cell. Amplitudes of EPSCs were normalized 
to baseline before and after application of SKF96365. (D) Summary 
bar graphs showing change of depression of EPSCs after appli-
cation of SKF96365.
Fig. 5. Endocannabinoid-mediated short-term depression in cere-
bellar Purkinje cell was not inhibited by BTP2. (A) Slow current 
traces evoked by 10 PF stimuli at 100 Hz during 5 μM of NBQX 
(Black: Control, Grey: 50 μM of BTP2). (B) Slow EPSCs were evoked
during a 200 seconds baseline and for 500 seconds after induction 
of transient depression application. After that, 50 μM of BTP2 was 
applied for 10 minutes, and then recording of baseline and 
induction of transient depression were established in the same cell. 
(C) EPSPs were evoked by paired pulse of PF stimulus during a 
40 seconds baseline and for 60 seconds after induction of transient 
depression. After that, 50 μM of BTP2 was applied for 10 minutes, 
and then recording of baseline and induction of transient 
depression were established in the same cell. Amplitudes of EPSCs 
were normalized to baseline before and after application of BTP2. 
(D) Summary bar graphs showing change of depression of EPSPs 
after application of BTP2. (E) EPSPs were evoked by paired pulse 
of PF stimulus during a 40 seconds baseline and for 60 seconds 
after induction of transient depression. After that, 50 μM of BTP2 
was applied for 10 minutes, and then recording of baseline and 
induction of transient depression were established in the same cell. 
Amplitudes of EPSCs were normalized to baseline before and after 
application of BTP2. (F) Summary bar graphs showing change of 
depression of EPSCs after application of BTP2.
most of the slow current. This means the action of 
SKF96365 was a nonspecific effect, although the mecha-
nism by which SKF96365 inhibited RER is unknown. Drugs 
like SKF96365 or ruthenium red have been used as TRP 
channel blockers so far, but now they are known to have 
nonspecific effects on Endoplasmic reticulum (ER) calcium 
stores or channels other than TRPC. BTP2 has been known 
to function as a store-operated Ca
2＋ channel/Ca
2＋ re-
lease-activated Ca
2＋ channel blocker [34,35], and inhibit 
overexpressed TRPC channels in HEK293 cells. BTP2 al-
most fully blocks TRPC at about 1 μM, and had little effect 
on ER, K
＋ channel or VOCC in cultured single cell. 
However, a concentration of BTP2 that blocks TRPC effec-
tively in brain slices has not been reported yet. We found 
that 50 μM of BTP2 is needed to block the slow current; 
it is much larger than the concentration that blocks TRPC 
in cultured single cell, and specificity of BTP2 to TRPC at 
this concentration is not clear yet. However, based on the 
fact that BTP2 did not affect endocannabinoid release, we 
conclude that TRPC does not contribute to endocannabinoid 
release although 50 μM of BTP2 may be nonspecific. The 
results described above suggest that BTP2 can be an alter-
native or additional option as a pharmacologic blocker of 
TRP channels.
  The role of VOCC or ER calcium stores as a calcium 
source is well known, while that of calcium influx through 
TRPC is unclear. We investigated a possibility that TRPC 
plays a role as a novel calcium source other than VOCC 
or ER calcium store in Ca-RER, however, TRPC did not 
affect endocannabinoid release. It was also revealed pre-
viously that ER calcium store has little effect on the ele-
vation of calcium concentration and endocannabinoid re-
lease [22]. Based on these findings, there is a large possi-
bility that VOCC acts as the critical and sole calcium 
source. We could not induce transient depression by only 
PF burst on voltage clamp mode at −70 mV, unlike associa-
tive stimulation or PF burst on current clamp mode, which 
VOCC can activate by; this data is consistent with the idea 
that VOCC is the most important calcium source for endo-
cannabinoid release.Effects of TRPC Blockers on eCB Signaling 143
  Ca-RER can be induced by 1 μM or higher concentration 
of calcium [22]. Therefore, if calcium increase induced by 
VOCC was more than 1 μM and hence sufficient to mediate 
endocannabinoid release, TRPC-mediated calcium increase 
could be overwhelmed by the activation of VOCC. Thus, a 
possibility that TRPC can contribute to endocannabinoid 
release in the condition that VOCC activates to a lesser 
degree still remains. However, the amplitude of endocanna-
binoid-induced depression increases in a calcium dependent 
manner to almost 80% of control, up to calcium concen-
trations of 5 μM [22]. The amplitude of attenuation of 
EPSC we observed was about 50%, which is not maximal 
degree of endocannabinoid-mediated depression. If TRPC 
contributes to endocannabinoid release, BTP2 should in-
hibit the depression of EPSC at least partially in spite of 
VOCC. Therefore, our data suggest TRPC is not involved 
in endocannabinoid release.
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